Cargando…

Low toxic maghemite nanoparticles for theranostic applications

BACKGROUND: Iron oxide nanoparticles have numerous and versatile biological properties, ranging from direct and immediate biochemical effects to prolonged influences on tissues. Most applications have strict requirements with respect to the chemical and physical properties of such agents. Therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuchma, Elena A, Zolotukhin, Peter V, Belanova, Anna A, Soldatov, Mikhail A, Lastovina, Tatiana A, Kubrin, Stanislav P, Nikolsky, Anatoliy V, Mirmikova, Lidia I, Soldatov, Alexander V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587181/
https://www.ncbi.nlm.nih.gov/pubmed/28919740
http://dx.doi.org/10.2147/IJN.S140368
_version_ 1783261948356329472
author Kuchma, Elena A
Zolotukhin, Peter V
Belanova, Anna A
Soldatov, Mikhail A
Lastovina, Tatiana A
Kubrin, Stanislav P
Nikolsky, Anatoliy V
Mirmikova, Lidia I
Soldatov, Alexander V
author_facet Kuchma, Elena A
Zolotukhin, Peter V
Belanova, Anna A
Soldatov, Mikhail A
Lastovina, Tatiana A
Kubrin, Stanislav P
Nikolsky, Anatoliy V
Mirmikova, Lidia I
Soldatov, Alexander V
author_sort Kuchma, Elena A
collection PubMed
description BACKGROUND: Iron oxide nanoparticles have numerous and versatile biological properties, ranging from direct and immediate biochemical effects to prolonged influences on tissues. Most applications have strict requirements with respect to the chemical and physical properties of such agents. Therefore, developing rational design methods of synthesis of iron oxide nanoparticles remains of vital importance in nanobiomedicine. METHODS: Low toxic superparamagnetic iron oxide nanoparticles (SPIONs) for theranostic applications in oncology having spherical shape and maghemite structure were produced using the fast microwave synthesis technique and were fully characterized by several complementary methods (transmission electron microscopy [TEM], X-ray diffraction [XRD], dynamic light scattering [DLS], X-ray photoelectron spectroscopy [XPS], X-ray absorption near edge structure [XANES], Mossbauer spectroscopy, and HeLa cells toxicity testing). RESULTS: TEM showed that the majority of the obtained nanoparticles were almost spherical and did not exceed 20 nm in diameter. The averaged DLS hydrodynamic size was found to be ~33 nm, while that of nanocrystallites estimated by XRD waŝ16 nm. Both XRD and XPS studies evidenced the maghemite (γ-Fe(2)O(3)) atomic and electronic structure of the synthesized nanoparticles. The XANES data analysis demonstrated the structure of the nanoparticles being similar to that of macroscopic maghemite. The Mossbauer spectroscopy revealed the γ-Fe(2)O(3) phase of the nanoparticles and vibration magnetometry study showed that reactive oxygen species in HeLa cells are generated both in the cytoplasm and the nucleus. CONCLUSION: Quasispherical Fe(3+) SPIONs having the maghemite structure with the average size of 16 nm obtained by using the fast microwave synthesis technique are expected to be of great value for theranostic applications in oncology and multimodal anticancer therapy.
format Online
Article
Text
id pubmed-5587181
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55871812017-09-15 Low toxic maghemite nanoparticles for theranostic applications Kuchma, Elena A Zolotukhin, Peter V Belanova, Anna A Soldatov, Mikhail A Lastovina, Tatiana A Kubrin, Stanislav P Nikolsky, Anatoliy V Mirmikova, Lidia I Soldatov, Alexander V Int J Nanomedicine Original Research BACKGROUND: Iron oxide nanoparticles have numerous and versatile biological properties, ranging from direct and immediate biochemical effects to prolonged influences on tissues. Most applications have strict requirements with respect to the chemical and physical properties of such agents. Therefore, developing rational design methods of synthesis of iron oxide nanoparticles remains of vital importance in nanobiomedicine. METHODS: Low toxic superparamagnetic iron oxide nanoparticles (SPIONs) for theranostic applications in oncology having spherical shape and maghemite structure were produced using the fast microwave synthesis technique and were fully characterized by several complementary methods (transmission electron microscopy [TEM], X-ray diffraction [XRD], dynamic light scattering [DLS], X-ray photoelectron spectroscopy [XPS], X-ray absorption near edge structure [XANES], Mossbauer spectroscopy, and HeLa cells toxicity testing). RESULTS: TEM showed that the majority of the obtained nanoparticles were almost spherical and did not exceed 20 nm in diameter. The averaged DLS hydrodynamic size was found to be ~33 nm, while that of nanocrystallites estimated by XRD waŝ16 nm. Both XRD and XPS studies evidenced the maghemite (γ-Fe(2)O(3)) atomic and electronic structure of the synthesized nanoparticles. The XANES data analysis demonstrated the structure of the nanoparticles being similar to that of macroscopic maghemite. The Mossbauer spectroscopy revealed the γ-Fe(2)O(3) phase of the nanoparticles and vibration magnetometry study showed that reactive oxygen species in HeLa cells are generated both in the cytoplasm and the nucleus. CONCLUSION: Quasispherical Fe(3+) SPIONs having the maghemite structure with the average size of 16 nm obtained by using the fast microwave synthesis technique are expected to be of great value for theranostic applications in oncology and multimodal anticancer therapy. Dove Medical Press 2017-08-31 /pmc/articles/PMC5587181/ /pubmed/28919740 http://dx.doi.org/10.2147/IJN.S140368 Text en © 2017 Kuchma et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kuchma, Elena A
Zolotukhin, Peter V
Belanova, Anna A
Soldatov, Mikhail A
Lastovina, Tatiana A
Kubrin, Stanislav P
Nikolsky, Anatoliy V
Mirmikova, Lidia I
Soldatov, Alexander V
Low toxic maghemite nanoparticles for theranostic applications
title Low toxic maghemite nanoparticles for theranostic applications
title_full Low toxic maghemite nanoparticles for theranostic applications
title_fullStr Low toxic maghemite nanoparticles for theranostic applications
title_full_unstemmed Low toxic maghemite nanoparticles for theranostic applications
title_short Low toxic maghemite nanoparticles for theranostic applications
title_sort low toxic maghemite nanoparticles for theranostic applications
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587181/
https://www.ncbi.nlm.nih.gov/pubmed/28919740
http://dx.doi.org/10.2147/IJN.S140368
work_keys_str_mv AT kuchmaelenaa lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT zolotukhinpeterv lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT belanovaannaa lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT soldatovmikhaila lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT lastovinatatianaa lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT kubrinstanislavp lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT nikolskyanatoliyv lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT mirmikovalidiai lowtoxicmaghemitenanoparticlesfortheranosticapplications
AT soldatovalexanderv lowtoxicmaghemitenanoparticlesfortheranosticapplications